|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Tuesday, April 29
by
multiplesclerosis
on Tue 29 Apr 2008 02:00 AM CST
Currently, there is no single diagnostic test for RLS. The disorder is diagnosed clinically by evaluating the patient's history and symptoms. Despite a clear description of clinical features, the condition more »
by
multiplesclerosis
on Tue 29 Apr 2008 12:00 AM CST
Combination therapies in multiple sclerosis. The last years have seen enormous progress in our understanding of pathophysiology (1) of multiple sclerosis. In addition, the armamentarium (2) of available immunomodulatory or immunosuppressive therapies (3) has greatly increased, especially for the relapsing remitting form of the disease. Since their therapeutic efficacy is often limited in individual patients, it is conceivable that combination therapies may bring improved clinical efficacy while managing increasing side effects and toxicity. The combination of agents with additive or synergistic modes of action is of particular interest. Combination of the two classes of recognised first-line treatment, a beta-interferon and glatiramer acetate is currently under evaluation in a large Phase III trial. However, there are theoretical reasons for thinking that such a combination may not be particularly beneficial. None of the combination studies performed with beta-interferons to date have shown unequivocal evidence of benefit, including combinations with statins, natalizumab, and azathioprine. On the other hand, for glatiramer acetate, the combination with mitoxantrone used as induction therapy may be of interest and preliminary data on combination with minocycline are also promising. University of Bochum, St. Josef-Hospital, Dept. of Neurology, Gudrunstr. 56, 44791, Bochum, Germany. Terms:
by
multiplesclerosis
on Tue 29 Apr 2008 12:00 AM CST
In small studies, cooling techniques, or lowering the body temperature, has been reported to improve multiple symptoms among people with MS. In one such small study of eight patients, an improvement was seen in one patient’s ability to more »
|
||